IL221607B
Compositions comprising a targeted bifunctional fusion molecule, wherein said molecule comprises a targeting moiety and an immunomodulatory moiety
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
51 members in 10 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 31125510 | United States of America | P | |
| 201161435671 | United States of America | P | |
| 2011027317 | United States of America | W |
Members51
| Document | Office | Kind | |
|---|---|---|---|
| CA2791383A1 | Canada | A1 | |
| CA3083324A1 | Canada | A1 | |
| WO2011109789A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2011109789A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP2542590A2 | European Patent Office (EPO) | A2 | |
| US2013039911A1 | United States of America | A1 | |
| JP2013521311A | Japan | A | |
| EP2542590A4 | European Patent Office (EPO) | A4 | |
| US8993524B2 | United States of America | B2 | |
| US2015183881A1 | United States of America | A1 | |
| US9441044B2 | United States of America | B2 | |
| US2016340430A1 | United States of America | A1 | |
| JP6066732B2 | Japan | B2 | |
| JP2017043600A | Japan | A | |
| EP2542590B1 | European Patent Office (EPO) | B1 | |
| US2017158770A1 | United States of America | A1 | |
| DK2542590T3 | Denmark | T3 | |
| PT2542590T | Portugal | T | |
| ES2638521T3 | Spain | T3 | |
| PL2542590T3 | Poland | T3 | |
| US9850306B2 | United States of America | B2 | |
| EP3260470A1 | European Patent Office (EPO) | A1 | |
| JP6378262B2 | Japan | B2 | |
| JP2018172439A | Japan | A | |
| IL266971D0 | Israel | D0 | |
| US10442860B2 | United States of America | B2 | |
| EP2542590B2 | European Patent Office (EPO) | B2 | |
| US2020115455A1 | United States of America | A1 | |
| IL221607A | Israel | A | |
| IL221607BThis record | Israel | B | |
| DK2542590T4 | Denmark | T4 | |
| PL2542590T5 | Poland | T5 | |
| ES2638521T5 | Spain | T5 | |
| EP3798237A1 | European Patent Office (EPO) | A1 | |
| JP2021143189A | Japan | A | |
| US11274156B2 | United States of America | B2 | |
| IL266971A | Israel | A | |
| IL266971B | Israel | B | |
| US2022204628A1 | United States of America | A1 | |
| IL293220A | Israel | A | |
| CA2791383C | Canada | C | |
| JP7212468B2 | Japan | B2 | |
| IL293220B1 | Israel | B1 | |
| IL300733A | Israel | A | |
| IL293220B2 | Israel | B2 | |
| US2025009772A1 | United States of America | A1 | |
| US12295968B2 | United States of America | B2 | |
| IL300733B1 | Israel | B1 | |
| IL323000A | Israel | A | |
| CA3253628A1 | Canada | A1 | |
| IL300733B2 | Israel | B2 |
3 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent renewedKB | KB | |
| Patent renewedKB | KB | |
| Patent grantedGrantedFF | FF |
Numbers
- Publication
- 221607
- Application
- 22160712
Titles
- English
- Compositions comprising a targeted bifunctional fusion molecule, wherein said molecule comprises a targeting moiety and an immunomodulatory moiety
Classification
- CPC, 37
- A61K31/704
- C07K16/2827
- C07K14/70532
- C07K14/70575
- C07K14/70578
- C07K14/70596
- C07K14/71
- C07K16/28
- C07K2319/00
- C07K16/2812
- C07K16/2815
- C07K16/2851
- A61K2039/505
- C07K2317/73
- C07K2317/76
- C07K14/495
- A61K47/6803
- A61K38/179
- A61P29/00
- A61P35/00
- A61P37/00
- A61P37/02
- A61P37/04
- A61P37/06
- A61P43/00
- A61K2039/572
- A61K39/3955
- A61K39/39558
- A61K45/06
- C07K16/2863
- C07K16/2866
- C07K16/30
- C07K2317/33
- C07K2317/526
- C07K2317/622
- C07K2319/70
- C07K19/00
- IPC, 1
- A61K39 00